Named on one round in the feed.
Since 2024-12-24
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Hangzhou Eli Radiopharma Co., Ltd. Eli Radiopharma specializes in the innovation of radioactive diagnostic and therapeutic drugs for cancer and neurodegenerative diseases. | Pre-seed Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $13.7M | 2024-12-24 | [ PART ] |